Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Metronidazole is an antibiotic and antiprotozoal medication, with the chemical formula C6H9N3O3 of can be used either alone or with other antibiotics to treat pelvic inflammatory disease, endocarditis, and bacterial vaginosis among others. Metronidazole is white crystalline powder, which can also be called as Fragyl Orvagil, Trichazol, Metronid, etc.
The metronidazole industry concentration is not high. In the world wide, China has a long history and unshakable status in this industry and the giant manufactures mainly focus in Hubei province，such as Hongyuan and Yinhe. With the future capacity growth, China metronidazole production is in the rising trend.
With the raw material changes, the global metronidazole average price is in the decline trend. The global metronidazole production shows an increasing trend.
All manufactures in the world are committed to the improvement of the metronidazole industry. In two years, with the development of the metronidazole industry, waste water has become a serious source of pollution. Therefore some companies mainly pay attention to improving technology process, in order to form circular production and reduce costs.
We tend to believe this industry now is close to mature, and the consumption increasing degree will show a smooth curve. On product prices, the slow downward trend in recent years will maintain in the future, as competition intensifies.
Market Analysis and Insights: Global Metronidazole Market
The global Metronidazole market was valued at US$ 113.3 in 2020 and will reach US$ 109.9 million by the end of 2027, growing at a CAGR of -0.5% during 2022-2027.
Global Metronidazole Scope and Market Size
The global Metronidazole market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metronidazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Glyoxal Process
Ethidene Diamine Process
Others
Segment by Application
Metronidazole Tablets
Metronidazole Capsule
Metronidazole Injection
Others
The Metronidazole market is analysed and market size information is provided by regions (countries). Segment by Application, the Metronidazole market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Hongyuan Pharmaceutical
Yinhe Aarti Pharmaceutical
Saikang Pharmaceutical
Zhongan Pharmaceutical
Wuyao Pharmaceutical
Yichang Changjiang Pharmaceutical
Tongji Pharmaceutical
Hongda Pharmaceutical
Topsun Pharmaceutical
Unichem Laboratories
CordenPharma Farchemia
API Polpharma
Manav Drugs
Aarey Drugs & Pharmaceuticals
Aarti Drugs
The metronidazole industry concentration is not high. In the world wide, China has a long history and unshakable status in this industry and the giant manufactures mainly focus in Hubei province，such as Hongyuan and Yinhe. With the future capacity growth, China metronidazole production is in the rising trend.
With the raw material changes, the global metronidazole average price is in the decline trend. The global metronidazole production shows an increasing trend.
All manufactures in the world are committed to the improvement of the metronidazole industry. In two years, with the development of the metronidazole industry, waste water has become a serious source of pollution. Therefore some companies mainly pay attention to improving technology process, in order to form circular production and reduce costs.
We tend to believe this industry now is close to mature, and the consumption increasing degree will show a smooth curve. On product prices, the slow downward trend in recent years will maintain in the future, as competition intensifies.
Market Analysis and Insights: Global Metronidazole Market
The global Metronidazole market was valued at US$ 113.3 in 2020 and will reach US$ 109.9 million by the end of 2027, growing at a CAGR of -0.5% during 2022-2027.
Global Metronidazole Scope and Market Size
The global Metronidazole market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metronidazole market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Glyoxal Process
Ethidene Diamine Process
Others
Segment by Application
Metronidazole Tablets
Metronidazole Capsule
Metronidazole Injection
Others
The Metronidazole market is analysed and market size information is provided by regions (countries). Segment by Application, the Metronidazole market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Hongyuan Pharmaceutical
Yinhe Aarti Pharmaceutical
Saikang Pharmaceutical
Zhongan Pharmaceutical
Wuyao Pharmaceutical
Yichang Changjiang Pharmaceutical
Tongji Pharmaceutical
Hongda Pharmaceutical
Topsun Pharmaceutical
Unichem Laboratories
CordenPharma Farchemia
API Polpharma
Manav Drugs
Aarey Drugs & Pharmaceuticals
Aarti Drugs
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
